How cadmium exposure affects kidney function and drug processing
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney
This study looks at how long-term exposure to cadmium, a harmful metal, might change how your kidneys handle medications, helping us understand potential health risks and how it could affect your treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11063295 on NIH RePORTER |
What this research studies
This research investigates the impact of chronic low-level exposure to cadmium, a heavy metal, on the function of kidney transporter proteins that are crucial for drug disposition. The study aims to understand how cadmium affects the transport of various drugs across kidney cells, which could influence the effectiveness of treatments for diseases. By examining the mechanisms of renal transporters involved in drug processing, the research seeks to uncover potential health risks associated with cadmium exposure. Patients may benefit from insights into how their kidney function could be affected by environmental toxins and how this might impact their medication.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with chronic kidney conditions or those exposed to cadmium through environmental or occupational sources.
Not a fit: Patients who have no history of kidney issues or exposure to cadmium may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of how environmental toxins like cadmium affect drug metabolism, potentially enhancing treatment strategies for patients with kidney-related issues.
How similar studies have performed: While the effects of cadmium on health are well-documented, the specific investigation into its impact on kidney drug transporters is relatively novel and has not been extensively studied.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Shu, Yan — University of Maryland Baltimore
- Study coordinator: Shu, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.